Joel Greenblatt's EMN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 201,577 shares of Eastman Chemical Company (EMN) worth $12.71 M, representing 0.06% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in EMN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 161,191 shares. Largest reduction occurred in Q3 2019, reducing 124,123 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Eastman Chemical Company (EMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eastman Chemical Company (EMN) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +46,281 | New Buy | 46,281 | $80.70 |
| Q1 2014 | +32,580 | Add 70.40% | 78,861 | $86.21 |
| Q2 2014 | -17,571 | Reduce 22.28% | 61,290 | $87.36 |
| Q3 2014 | +31,250 | Add 50.99% | 92,540 | $80.89 |
| Q4 2014 | +110,210 | Add 119.09% | 202,750 | $75.86 |
| Q1 2015 | -202,750 | Sold Out | 202,750 | $0.00 |
| Q3 2015 | +182,989 | New Buy | 182,989 | $64.72 |
| Q4 2015 | -37,868 | Reduce 20.69% | 145,121 | $67.51 |
| Q1 2016 | -47,022 | Reduce 32.40% | 98,099 | $72.23 |
| Q2 2016 | -93,797 | Reduce 95.61% | 4,302 | $67.88 |
| Q3 2016 | +6,443 | Add 149.77% | 10,745 | $67.66 |
| Q4 2016 | +33,103 | Add 308.08% | 43,848 | $75.21 |
| Q1 2017 | -43,848 | Sold Out | 43,848 | $0.00 |
| Q4 2017 | +20,345 | New Buy | 20,345 | $92.65 |
| Q1 2018 | +36,591 | Add 179.85% | 56,936 | $105.57 |
| Q2 2018 | -27,030 | Reduce 47.47% | 29,906 | $99.95 |
| Q3 2018 | -17,362 | Reduce 58.06% | 12,544 | $95.74 |
| Q4 2018 | +47,597 | Add 379.44% | 60,141 | $73.11 |
| Q1 2019 | +161,191 | Add 268.02% | 221,332 | $75.88 |
| Q2 2019 | -40,226 | Reduce 18.17% | 181,106 | $77.83 |
| Q3 2019 | -124,123 | Reduce 68.54% | 56,983 | $73.83 |
| Q4 2019 | +49,974 | Add 87.70% | 106,957 | $79.26 |
| Q1 2020 | +11,599 | Add 10.84% | 118,556 | $46.58 |
| Q2 2020 | -48,716 | Reduce 41.09% | 69,840 | $69.64 |
| Q3 2020 | -32,132 | Reduce 46.01% | 37,708 | $78.13 |
| Q4 2020 | +2,374 | Add 6.30% | 40,082 | $100.27 |
| Q1 2021 | -13,451 | Reduce 33.56% | 26,631 | $110.13 |
| Q2 2021 | -8,792 | Reduce 33.01% | 17,839 | $116.77 |
| Q3 2021 | +2,337 | Add 13.10% | 20,176 | $100.76 |
| Q4 2021 | +5,838 | Add 28.94% | 26,014 | $120.90 |
| Q1 2022 | +23,285 | Add 89.51% | 49,299 | $112.05 |
| Q2 2022 | -22,873 | Reduce 46.40% | 26,426 | $89.76 |
| Q3 2022 | +78,454 | Add 296.88% | 104,880 | $71.05 |
| Q4 2022 | -33,394 | Reduce 31.84% | 71,486 | $81.44 |
| Q1 2023 | -14,479 | Reduce 20.25% | 57,007 | $84.34 |
| Q2 2023 | -23,456 | Reduce 41.15% | 33,551 | $83.72 |
| Q3 2023 | -27,564 | Reduce 82.16% | 5,987 | $76.72 |
| Q4 2023 | +28,864 | Add 482.11% | 34,851 | $89.82 |
| Q1 2024 | +2,447 | Add 7.02% | 37,298 | $100.22 |
| Q2 2024 | -24,803 | Reduce 66.50% | 12,495 | $97.97 |
| Q3 2024 | +15,091 | Add 120.78% | 27,586 | $111.95 |
| Q4 2024 | +60,177 | Add 218.14% | 87,763 | $91.32 |
| Q1 2025 | +7,875 | Add 8.97% | 95,638 | $88.11 |
| Q2 2025 | -1,279 | Reduce 1.34% | 94,359 | $74.66 |
| Q3 2025 | +107,218 | Add 113.63% | 201,577 | $63.05 |
Joel Greenblatt's Eastman Chemical Company Investment FAQs
Joel Greenblatt first purchased Eastman Chemical Company (EMN) in Q4 2013, acquiring 46,281 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Eastman Chemical Company (EMN) for 48 quarters since Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Eastman Chemical Company (EMN) was in Q3 2015, adding 182,989 shares worth $11.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 201,577 shares of Eastman Chemical Company (EMN), valued at approximately $12.71 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Eastman Chemical Company (EMN) represents approximately 0.06% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Eastman Chemical Company (EMN) was 221,332 shares, as reported at the end of Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.